TRDMT1 and cancer: When targeting other RNA epigenetic modification processes and corresponding regulatory proteins, a study found that using azacytidine to completely inhibit DNMT2-mediated tRNA m5C methylation can significantly reduce cancer cell proliferation, which supports the idea that reducing tRNA m5C methylation may be an effective cancer therapeutic strategy (Cheng et al., 2018).